Our findings suggested that Acod1/Itaconate axis might be an effective therapeutic treatment for mice with obesity-induced pulmonary microvascular endotheliopathy by activating Nrf2. This evidence concerns the gene NFE2L2 and obesity due to melanocortin 4 receptor deficiency.